Chi Fong
Stock Analyst at B of A Securities
(0.34)
# 3,132
Out of 4,479 analysts
6
Total ratings
50%
Success rate
-29.91%
Average return
Main Sectors:
Top Industries:
3 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ROIV Roivant Sciences | Maintains: Neutral | $11 → $12 | $10.56 | +13.64% | 2 | Jan 2, 2024 | |
| CCCC C4 Therapeutics | Maintains: Neutral | $5 → $2 | $4.52 | -55.75% | 3 | Oct 9, 2023 | |
| FHTX Foghorn Therapeutics | Initiates: Buy | $10 | $5.44 | +83.82% | 1 | Mar 28, 2023 |
Roivant Sciences
Jan 2, 2024
Maintains: Neutral
Price Target: $11 → $12
Current: $10.56
Upside: +13.64%
C4 Therapeutics
Oct 9, 2023
Maintains: Neutral
Price Target: $5 → $2
Current: $4.52
Upside: -55.75%
Foghorn Therapeutics
Mar 28, 2023
Initiates: Buy
Price Target: $10
Current: $5.44
Upside: +83.82%